telehealth News & Analysis
3 articles
Market Mood
Hims & Hers (HIMS) Reports 3% Stock Decline After Q2 Loss
Hims & Hers Health (HIMS) stock declined 3% before trimming losses on August 11, 2026. The company reported a loss of $0.37 per share in Q2, down from a profit of $0.17 per share in the same period last year, with gross margins decreasing to 64% from 76%. This performance was affected by a one-time cost of $81 million, associated with the acquisition of Eucalyptus and restructuring due to changes in their weight-loss strategy. These financial results highlight the ongoing regulatory challenges and shifts in strategy, which are significant for investors tracking the company's performance.
Read More: Hims & Hers (HIMS) Reports 3% Stock Decline After Q2 Loss
Teladoc (TDOC), GoodRx shares drop after OpenAI health feature launch
Shares of Teladoc (TDOC) and GoodRx declined following the launch of a new health feature by OpenAI. This development has generated concern among investors about the potential impact on both companies' market positions. The exact percentage of the drop in share prices was not specified. The launch of AI-powered health tools by OpenAI could intensify competition in the telehealth sector, prompting investors to reassess the future profitability of Teladoc and GoodRx. Investors should monitor these developments as they may affect the performance of TDOC and GoodRx.
Read More: Teladoc (TDOC), GoodRx shares drop after OpenAI health feature launch
Whoop (WHOOP) Introduces On-Demand Clinician Access Feature
Fitness wearable Whoop (WHOOP) announced that its users will soon gain access to on-demand video consultations with licensed clinicians. This feature aims to enhance user health support and integrates new AI capabilities. The innovation is relevant to the growing demand for telehealth services in the fitness and wellness sector. By providing direct clinician access, Whoop may strengthen its market position as digital health solutions become increasingly important.
Read More: Whoop (WHOOP) Introduces On-Demand Clinician Access Feature